Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs D Wave Quantum Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while D Wave Quantum Inc trades at $11.64 (market cap $4.57B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and D Wave Quantum Inc for 33 Days on average.
| KYMR | QBTS | |
|---|---|---|
Market Cap | $8.88B | $4.57B |
Volume | 1,028,790 | 23,941,483 |
Sector | Health | Technology |
52-Week High | $127.31 | $44.78 |
52-Week Low | $55.80 | $12.03 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $8.27B | $4.07B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
D-Wave Quantum (QBTS) trades at $13.38, down 2.62% with bearish technical signals despite unanimous analyst buy ratings. The company shows significant financial challenges with a P/S ratio of 347.19 and negative profitability metrics, though it maintains a 64.19% gross margin. Recent news highlights ongoing fraud investigations alongside positive business developments in quantum computing technology.
While analyst consensus projects 157% upside to $34.38 price target, substantial risks include negative cash flows, high valuation multiples, and legal uncertainties. The stock presents high-risk/high-reward potential for investors comfortable with quantum computing volatility and current financial headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
